Evidence for low high-density lipoprotein cholesterol levels in Australian indigenous peoples: a systematic review

Abstract

BackgroundLow plasma high-density lipoprotein cholesterol (HDL-C) levels are a strong, independent, but poorly understood risk factor for cardiovascular disease (CVD). Although this atherogenic lipid abnormality has been widely reported in Australia’s Indigenous peoples, Aboriginal and Torres Strait Islanders, the evidence has not come under systematic review. This review therefore examines published data for Indigenous Australians reporting 1) mean HDL-C levels for both sexes and 2) factors associated with low HDL-C.MethodsPubMed, Medline and Informit ATSI Health databases were systematically searched between 1950 and 2012 for studies on Indigenous Australians reporting mean HDL-C levels in both sexes. Retrieved studies were evaluated by standard criteria. Low HDL-C was defined as: <1.0 mmol/L. Analyses of primary data associating measures of HDL-C with other CVD risk factors were also performed.ResultsFifteen of 93 retrieved studies were identified for inclusion. These provided 58 mean HDL-C levels; 29 for each sex, most obtained in rural/regional (20%) or remote settings (60%) and including 51–1641 participants. For Australian Aborigines, mean HDL-C values ranged between 0.81-1.50 mmol/L in females and 0.76-1.60 mmol/L in males. Two of 15 studies reported HDL-C levels for Torres Strait Islander populations, mean HDL-C: 1.00 or 1.11 mmol/L for females and 1.01 or 1.13 mmol/L for males. Low HDL-C was observed only in rural/regional and remote settings - not in national or urban studies (n = 3) in either gender. Diabetes prevalence, mean/median waist-to-hip ratio and circulating C-reactive protein levels were negatively associated with HDL-C levels (all P < 0.05). Thirty-four per cent of studies reported lower mean HDL-C levels in females than in males.ConclusionsVery low mean HDL-C levels are common in Australian Indigenous populations living in rural and remote communities. Inverse associations between HDL-C and central obesity, diabetes prevalence and inflammatory markers suggest a particularly adverse CVD risk factor profile. An absence of sex dichotomy in HDL-C levels warrants further investigation.

The Australian Aboriginal Birth Cohort study: socio‐economic status at birth and cardiovascular risk factors to 25 years of age

“…The importance of social factors — education, inequities in resource allocation, employment opportunities, physical infrastructure — must also be taken into account . Finally, genetic and inflammatory factors play important roles in determining serum lipid levels in Indigenous Australians . In a medium‐sized study in southeast Queensland ( N = 155), apolipoprotein E4 polymorphisms associated with high triglyceride and low HDL‐cholesterol levels were 80% more frequent among Indigenous than among non‐Indigenous participants …”

Nuclear Magnetic Resonance (NMR) Spectroscopy on the Effect of PCSK9 Inhibitor on Lipoprotein Particles in Patients With Acute Coronary Syndromes(ACS)

“…There are around 290 million patients with cardiovascular diseases in China, accounting for 40% of disease deaths, presenting tremendous difficulties in prevention and treatment of the disease. Dyslipidemia, especially elevated levels of low-density lipoprotein cholesterol (LDL cholesterol, or LDL-C), is the major factor for ASCVD [1][2] , making it the primary subject in the prevention and treatment of cardiovascular diseases to control blood lipids. In the Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults issued in 2016, LDL-C was regarded as the most important indicator for early warning, medication modification, and lipid monitoring in ASCVD patients.…”

Novel findings in relation to multiple anti‐atherosclerotic effects of XueZhiKang in humans

“… 1 Previous studies have confirmed that dyslipidemia, especially increased low-density lipoprotein (LDL) cholesterol (LDL-C) levels, is the most important risk factor for ASCVD, including coronary artery disease (CAD). 2 , 3 ASCVD is a well-known inflammatory disease that is also related to oxidative stress. 4 Previous data have shown that inflammation is an important feature of atherosclerotic lesions.…”